Showing results (1461-1470 of 2,361) with videos related to
Sort By:
Pageof 237
Clinical Neuropharmacology|July 21, 2006
Increased suicidal risk among smoking schizophrenia patientsIulian Iancu, Anna Piccone Sapir, Ginette Shaked, et al.Clinical Neuropharmacology|July 21, 2006
Rotigotine transdermal patch enables rapid titration to effective doses in advanced-stage idiopathic Parkinson disease: subanalysis of a parallel group, open-label, dose-escalation studyTomislav Babic, Bernard Boothmann, Jiri Polivka, et al.Clinical Neuropharmacology|January 1, 1991
Duration of neuroleptic treatment and relapse rate: a 5-year follow-up study with haloperidol decanoateH A YoussefClinical Neuropharmacology|January 1, 1991
Minimal effective dose and relapse--double-blind trial: haloperidol decanoate vs. placeboK Eklund, A ForsmanClinical Neuropharmacology|November 11, 2006
Therapeutic monitoring of valproate in psychiatry: how far have we progressed?Jessica Fleming, Manoranjenni ChettyClinical Neuropharmacology|February 3, 2007
A double-blind, randomized, crossover study of prosigne versus botox in patients with blepharospasm and hemifacial spasmCarlos R M Rieder, Pedro Schestatsky, Mariana Peixoto Socal, et al.Clinical Neuropharmacology|February 3, 2007
Tegaserod in constipation associated with Parkinson diseaseJohn C Morgan, Kapil D SethiClinical Neuropharmacology|February 3, 2007
Optic neuropathy related to hydrogen peroxide inhalationFüsun M Domaç, Abdulkadir Koçer, Remzi TanidirClinical Neuropharmacology|September 9, 2006
Comparison of dapoxetine versus paroxetine in patients with premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized studyMohammad Reza SafarinejadPageof 237